Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (Feb 1998). “Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding conduct”. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (Mar 1998). “Orexins and orexin receptors: a household of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding conduct”. Flier JS, Maratos-Flier E (Feb 1998). “Obesity and the hypothalamus: novel peptides for new pathways”. Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (Jan 1998). “The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity”. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E (Sep 2000). “A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains”.

Meerabux J, Iwayama Y, Sakurai T, Ohba H, Toyota T, Yamada K, Nagata R, Irukayama-Tomobe Y, Shimizu H, Yoshitsugu K, Ohta K, Yoshikawa T (Sep 2005). “Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects”. Ziolkowska A, Spinazzi R, Albertin G, Nowak M, Malendowicz LK, Tortorella C, Nussdorfer GG (Sep 2005). “Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, solely appearing through the OX1 receptor”. Spinazzi R, Rucinski M, Neri G, Malendowicz LK, Nussdorfer GG (Jun 2005). “Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and development of tumor cells”. Holmqvist T, Johansson L, Ostman M, Ammoun S, Akerman KE, Kukkonen JP (Feb 2005). “OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms”. Wieland HA, Söll RM, Doods HN, Stenkamp D, Hurnaus R, Lämmle B, Beck-Sickinger AG (Feb 2002). “The SK-N-MC cell line expresses an orexin binding site totally different from recombinant orexin 1-type receptor”.

Willie JT, Chemelli RM, Sinton CM, Yanagisawa M (2001). “To eat or to sleep? Orexin within the regulation of feeding and wakefulness”. ↑ Murray JA, Moore SB, Van Dyke CT, Lahr BD, Dierkhising RA, Zinsmeister AR, Melton LJ, Kroning CM, El-Yousseff M, Czaja AJ (December 2007). “HLA DQ gene dosage and danger and severity of celiac illness”. ↑ Gartlon J, Parker F, Harrison DC, Douglas SA, Ashmeade TE, Riley GJ, Hughes ZA, Taylor SG, Munton RP, Hagan JJ, Hunter JA, Jones DN (2001). “Central results of urotensin-II following ICV administration in rats”. ↑ Redondo MJ, Fain PR, Eisenbarth GS (2001). “Genetics of kind 1A diabetes”. Hungs M, Mignot E (May 2001). “Hypocretin/orexin, sleep and narcolepsy”. Synthetic research have proposed that cortistatins A and J may come up from cortistatin L, or from a precursor of equal oxidation state, with cortistatin L itself potentially generated by C2 oxidation of cortistatin Ok. Cortistatins A, J, Okay, and L have been synthesized by parallel routes from closely related intermediates derived from a common precursor.

↑ Schmidt H, Williamson D, Ashley-Koch A (May 2007). “HLA-DR15 haplotype and multiple sclerosis: a huge overview”. ↑ Killgore WD (1 January 2010), Kerkhof GA, Dongen HP (eds.), Results of sleep deprivation on cognition, Progress in Brain Analysis, vol. This web page was final edited on four June 2026, at 22:09 (UTC). This page was final edited on 3 September 2026, at 21:Eleven (UTC). Those gaps create protocol-mapping danger even when purity numbers look attractive on a gross sales page. Page was rendered with Parsoid. Yes, we carry out rigorous third-get together testing on each batch to ensure the product is protected and free from harmful levels of heavy metals. All the product info on this web site is for educational objective only. You will help Wikipedia by including lacking info. Overview of all of the structural data obtainable in the PDB for UniProt: P01920 (HLA class II histocompatibility antigen, DQ beta 1 chain) on the PDBe-KB. Major histocompatibility complex, class II, DQ beta 1, also referred to as HLA-DQB1, is a human gene and likewise denotes the genetic locus that accommodates this gene. Cortistatin is a 112-amino-acid protein encoded by the preprocortistatin gene, which contains a number of potential endoproteolytic cleavage websites.